Alessandra Canuto1, Kerstin Weber2, Marc Baertschi3, Sylke Andreas4, Jana Volkert5, Maria Christina Dehoust6, Susanne Sehner7, Anna Suling7, Karl Wegscheider7, Berta Ausín8, Mike J Crawford9, Chiara Da Ronch10, Luigi Grassi10, Yael Hershkovitz11, Manuel Muñoz8, Alan Quirk9, Ora Rotenstein11, Ana Belén Santos-Olmo8, Arieh Shalev12, Jens Strehle13, Hans-Ulrich Wittchen14, Holger Schulz6, Martin Härter6. 1. Nant Foundation, East Vaud Psychiatric Institute, Corsier-sur-Vevey, Switzerland. Electronic address: alessandra.canuto@nant.ch. 2. Division of Institutional Measures, Medical Direction, University Hospitals of Geneva, Puplinge, Switzerland. 3. Nant Foundation, East Vaud Psychiatric Institute, Corsier-sur-Vevey, Switzerland. 4. Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute for Psychology, Alpen-Adria Universität Klagenfurt, Klagenfurt, Austria; University Witten/Herdecke, Witten, Germany. 5. Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Psychosocial Prevention, University of Heidelberg, Heidelberg, Germany. 6. Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 7. Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 8. School of Psychology, Complutense University of Madrid, Madrid, Spain. 9. College Center for Quality Improvement, Royal College of Psychiatrists, London, UK. 10. Department of Biomedical and Specialty Surgical Sciences, Institute of Psychiatry, University of Ferrara, Ferrara, Italy. 11. Department of Psychiatry, Hadassah University Medical Center, Jerusalem, Israel. 12. Department of Psychiatry, Langone Medical Center, New York, NY, USA. 13. Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany. 14. Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität, Munich, Germany.
Abstract
OBJECTIVES: Previous estimates of the prevalence of anxiety disorders in late life vary greatly due to the lack of reliable diagnostic tools. This MentDis_ICF65+ study assessed 12-month prevalence rates of anxiety disorders and age- and gender-related differences in comorbidities, as well as impact on quality of life. DESIGN: The study used a cross-sectional multicenter survey. PARTICIPANTS: The study sample comprised 3,142 men and women aged 65 to 84 years, living in five European countries and Israel. MEASUREMENTS: Anxiety disorders were assessed using computer-assisted face-to-face interviews with an age-appropriate diagnostic interview (CIDI65+). RESULTS: The prevalence of anxiety disorders was 17.2%. Agoraphobia was the most frequent disorder (4.9%), followed by panic disorder (3.8%), animal phobia (3.5%), general anxiety disorder (3.1%), post-traumatic stress disorder (1.4%), social phobia (1.3%), and obsessive-compulsive disorder (0.8%). The prevalence rate of any anxiety disorder dropped by 40% to 47% in adults aged 75-84 years compared with those aged 65-74 years. Women were twice as likely to present with agoraphobia or general anxiety disorder as men. Only panic disorder and phobia were associated with comorbid major depression. The negative relationship with quality of life was limited to agoraphobia and generalized anxiety disorder. CONCLUSIONS: The age-appropriate CIDI65+ led to higher prevalence rates of anxiety disorders in the elderly, yet to weaker associations with comorbidities and impaired quality of life compared with previous studies.
OBJECTIVES: Previous estimates of the prevalence of anxiety disorders in late life vary greatly due to the lack of reliable diagnostic tools. This MentDis_ICF65+ study assessed 12-month prevalence rates of anxiety disorders and age- and gender-related differences in comorbidities, as well as impact on quality of life. DESIGN: The study used a cross-sectional multicenter survey. PARTICIPANTS: The study sample comprised 3,142 men and women aged 65 to 84 years, living in five European countries and Israel. MEASUREMENTS: Anxiety disorders were assessed using computer-assisted face-to-face interviews with an age-appropriate diagnostic interview (CIDI65+). RESULTS: The prevalence of anxiety disorders was 17.2%. Agoraphobia was the most frequent disorder (4.9%), followed by panic disorder (3.8%), animal phobia (3.5%), general anxiety disorder (3.1%), post-traumatic stress disorder (1.4%), social phobia (1.3%), and obsessive-compulsive disorder (0.8%). The prevalence rate of any anxiety disorder dropped by 40% to 47% in adults aged 75-84 years compared with those aged 65-74 years. Women were twice as likely to present with agoraphobia or general anxiety disorder as men. Only panic disorder and phobia were associated with comorbid major depression. The negative relationship with quality of life was limited to agoraphobia and generalized anxiety disorder. CONCLUSIONS: The age-appropriate CIDI65+ led to higher prevalence rates of anxiety disorders in the elderly, yet to weaker associations with comorbidities and impaired quality of life compared with previous studies.
Authors: Terence W H Chong; Scherazad Kootar; Helen Wilding; Sarah Berriman; Eleanor Curran; Kay L Cox; Alex Bahar-Fuchs; Ruth Peters; Kaarin J Anstey; Christina Bryant; Nicola T Lautenschlager Journal: Ther Adv Psychopharmacol Date: 2022-07-07
Authors: Richard C Oude Voshaar; Ton D F Dhondt; Mario Fluiter; Paul Naarding; Sanne Wassink; Maureen M J Smeets; Loeki P R M Pelzers; Astrid Lugtenburg; Martine Veenstra; Radboud M Marijnissen; Gert-Jan Hendriks; Lia A Verlinde; Robert A Schoevers; Rob H S van den Brink Journal: BMC Psychiatry Date: 2019-06-17 Impact factor: 3.630
Authors: Berta Ausín; Manuel Muñoz; Miguel Ángel Castellanos; Sara García Journal: Int J Environ Res Public Health Date: 2020-03-15 Impact factor: 3.390
Authors: Jorge A Sierra-Fonseca; Lyonna F Parise; Francisco J Flores-Ramirez; Eden H Robles; Israel Garcia-Carachure; Sergio D Iñiguez Journal: Chronic Stress (Thousand Oaks) Date: 2019-12-24